GCG and metabolic syndrome: In addition, the therapeutic effects of metformin in treating antipsychotic-inducted dyslipidemia may be associated with its role in the neuronal reduction of endogenous glucose production, increasing glucagon-like peptide-1 production, decreasing bile acid concentration in enterocytes, and modulating the gut microbiota56.